Weight Loss Drug May Cut 80% Risk Of Diabetes –

The results of the international clinical trial showed that liraglutide promoted weight loss by interacting with the areas of the brain that control appetite and energy intake.

Published in the journal The Lancet, the results showed that three years of continuous treatment with once-daily liraglutide 3.0 mg, in combination with diet and increased physical activity, reduced the risk of developing the Type 2 diabetes.

In fact, in 60 per cent of those patients with borderline diabetes the condition was reversed, and patients returned to healthy blood sugar levels, the study showed. 

Use your ← → (arrow) keys to browse

Next post:

Previous post: